B7-H3 overexpression in oral cancer

Oral Diseases

Volumn 22, Issue 3, 2016, Pages 163-165

  Coletta, R D ^a   Leme, A F P ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

B7 H3 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; B7 ANTIGEN;

CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; METABOLISM; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA;

B7 ANTIGENS; CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS;

EID: 84959368638     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12413     Document Type: Note

References (20)

1. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005). Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114: 806-816.
2. Chen JT, Chen CH, Ku KL et al (2015). Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response. Proc Natl Acad Sci USA 112: 13057-13062.
3. Geng F, Shi BZ, Yuan YF, Wu XZ (2004). The expression of core fucosylated E-cadherin in cancer cells and lung cancer patients: prognostic implications. Cell Res 14: 423-433.
4. Kang FB, Wang L, Jia HC et al (2015). B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway. Cancer Cell Int 15: 45.
5. Liu H, Tekle C, Chen YW et al (2011). B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther 10: 960-971.
6. Loos M, Hedderich DM, Ottenhausen M et al (2009). Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. BMC Cancer 9: 463.
7. Lupu CM, Eisenbach C, Kuefner MA et al (2006). An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo. J Gastrointest Surg 10: 635-645.
8. Lupu CM, Eisenbach C, Lupu AD et al (2007). Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer. Oncol Rep 18: 745-748.
9. Nygren MK, Tekle C, Ingebrigtsen VA, Fodstad O (2011). B7-H3 and its relevance in cancer; immunological and non-immunological perspectives. Front Biosci (Elite Ed) 3: 989-993.
10. Sun J, Fu F, Gu W et al (2011). Origination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune system. PLoS One 6: e24751.
11. Sun J, Liu C, Gao L et al (2015). Correlation between B7-H3 expression and rheumatoid arthritis: a new polymorphism haplotype is associated with increased disease risk. Clin Immunol 159: 23-32.
12. Veenstra RG, Flynn R, Kreymborg K et al (2015). B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood 125: 3335-3346.
13. Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N (2006). Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem 281: 2572-2577.
14. Wang L, Kang FB, Shan BE (2014). B7-H3-mediated tumor immunology: friend or foe? Int J Cancer 134: 2764-2771.
15. Wang L, Cao NN, Wang S, Man HW, Li PF, Shan BE (2015). Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma. Tumour Biol doi: 10.1007/s13277-015-4132-5 [Epub ahead of print].
16. Warnakulasuriya S (2010). Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 46: 407-410.
17. Wu CP, Jiang JT, Tan M et al (2006). Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 12: 457-459.
18. Yamato I, Sho M, Nomi T et al (2009). Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 101: 1709-1716.
19. Zhang T, Jiang B, Zou ST, Liu F, Hua D (2015a). Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. World J Gastroenterol 21: 1804-1813.
20. Zhang W, Wang J, Wang Y et al (2015b). B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells. Onco Targets Ther 8: 1721-1733.